The global SRS treatment planning systems market size was valued at USD 1.9 billion in 2025 and is expected to reach USD 3.6 billion by 2033, at a CAGR of 8.3% during the forecast period
Growth is driven by increasing adoption of precision oncology and non-invasive brain tumor treatments
Rising incidence of neurological disorders and cancer cases is accelerating demand for advanced treatment planning solutions
Integration of AI-based imaging and real-time dose optimization is further supporting market expansion
4 Views